AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Nodus 1.129/5/2023 There was no difference in 1-year survival between patients with and without enlargement of PALN (median 201 vs. Patients with PALN enlargement have 2.13 times risk of having negative radiotherapy outcome (p = 0.02, OR 2.13, CI95% 1.12 - 4.07). There were no significant differences between the enlargement status of PALN and age (p = 0.829), age of first sexual intercourse (p = 0.33), parity (p = 0.642), mass diameter (p = 0.777). Results: Among 76 subjects studied, there were 4 (5.1%) subjects who had enlarged PALN. Cipto Mangunkusumo National General Hospital and underwent MRI examination before undergoing treatment in January 2016 to May 2017. The subjects of this study were all women with a primary diagnosis of stages IIB to IVB cervical cancer who came to the gynecological oncology clinic of Dr. Methods: An observational analytic study using a retrospective cohort method was done using consecutive sampling. There were no differences in 1 year survival between patients with advanced cervical cancer with enlargement PALN.Ībstract = "Objective: To determine whether there are differences in clinical response after radiotherapy and 1 year survival in patients with advanced cervical cancer with and without enlargement of PALN. Conclusions: Patients with PALN enlargement have increased risk of having negative radiotherapy outcome (p < 0.05). ![]() ![]() ![]() Objective: To determine whether there are differences in clinical response after radiotherapy and 1 year survival in patients with advanced cervical cancer with and without enlargement of PALN.
0 Comments
Read More
Leave a Reply. |